A unique technology platform

From host organisms to the production of new biomolecules… A complete in-house discovery pipeline  !

Proprietary Actinomycete collection



Hedera-22 has built its own actinomycetes library composed of strains collected in unfriendly environment with unique properties and more focussed and specific to the goal.

Bioinformatic predictive approaches

Based on a AI driven methodology, the original strategy developed by Hedera-22 accelerates the next generation biomolecule discovery (up to 180 times faster than traditional methods).

in silico identification of the bacteria able to biosynthesize cryptic compounds, their structure and bioactivity.

cutTing edge Metabolomics

State of the art molecular metabolomics equipment and methods for new biomolecule structure elucidation.

Molecular Microbiology

Improving production of new molecules with targeted genetic modifications. Bioactivity and ecotoxicity preliminary assays conducted in house.

The context

The challenge for better health and a better planet drives Hedera-22 towards the development of sustainable products for pharma and plant protection .

Building on our core competencies and accelerated process, we intend to partner with pharma and agro leaders to join them in the development of solutions for the future.

Natural Products

Usually more bioavailable, Natural Products are more likely to resemble biosynthetic intermediates or endogenous metabolites, and hence take advantage of active transport mechanisms .

Nature has learned to maintain low hydrophobicity and intermolecular H-bond donating potential when it needs to make biologically active compounds with high molecular weight and large numbers of rotatable bonds.

Natural products and their derivatives have been recognized for many years as a source of therapeutic agents and structural diversity .

By mimicking certain distribution properties of natural products, combinatorial compounds can be substantially more diverse and have greater biological relevance than purely synthetic compounds.

Our main activities & services

Next generation BIOMOLECULEs library

Pre-characterized biomolecule catalog available for screening for bioactivity of interest.

STRAIN IMPROVEMENT


Identification of optimal expression conditions for maximising the fermentation yield.

COLLABORATIVE RESEARCH

Identification of next generation biomolecules with pharma, agro or other activity in the scope of licensing or partnership agreement.

Our Team

Hedera 22 team is skilled, flexible and dynamic. It is supported by the 4 founders who bring their expertise, fame and passion.

Management

Valerie Renard

CEO

Pierre Tocquin

Scientific coordinator

Team

Balaji Rathod

Micro & Molecular Biology

Bastien Demouveaux

Micro & Molecular Biology

Lucas Rezende

Metabolomics and biomolecular chemistry

Gil Josse 

Metabolomics and biomolecular chemistry

Alice Jadoul

Lab Technician

Amandine Vanloo

Lab Technician

Philippe Goffin

BioInformatics

Aymeric Naome

BioInformatics

Founders & Scientific Advisors

Denis Baurain

Marc Hanikenne

Sebastien Rigali

Pierre Tocquin

about US

Science and technology for a better life.

Hedera-22 was created in 2015 as a spin-off from ULiege.

 Its first activity was based on the development of bioinformatic competencies and the informatic treatment of massive biological data combined with « omic » biology expertise (genomics, proteomics, metabolomics). 

In 2020, Hedera-22 raised funds to pursue its activity in a wider field. It positions itself as a partner to industries active in research and development of innovative products based on the use of new natural molecules with agronomic (such as fungicide, herbicide, pesticide), therapeutic (anti bacterial, anti infectious, anti cancer) or other interest.

Latest news

We are regularly expanding our team. Contact us for more info about open positions. (@ admin@hedera22.com )

Discover our recent research article written in collaboration with the University of Liège – InBioS Center for Protein Engineering, GIGA Proteomics Facility and Mass Spectrometry Laboratory MolSys Research Unit – describing the discovery of 43  novel ferroverdin-like compounds from Streptomyces lunaelactis  species. Our collaborative work uncovered putative novel CETP inhibitors structurally related to ferroverdins.

contact information

    HEDERA-22

    Boulevard du Rectorat, 27b

    4000 Liege – Belgium

    google.be :  50°34’41.3″N 5°34’32.9″E